Installer Kaleta App
Accès rapide & mode hors-ligne
The Serum Institute of India, founded in 1966 by Dr. Cyrus Poonawalla, is a prominent biotechnology and pharmaceutical company based in Pune, India. It has grown to become the world’s largest vaccine manufacturer by number of doses produced and sold globally. The institute’s mission is to produce high-quality vaccines at affordable prices, thereby improving public health worldwide. Its extensive portfolio includes vaccines for polio, diphtheria, tetanus, pertussis, and more, serving over 170 countries, including many across Africa.
The Serum Institute’s operations have had a profound impact on global health, particularly in developing regions. It produces over 1.5 billion doses annually, reaching millions of beneficiaries and playing a crucial role in eradicating diseases and preventing outbreaks. Its flagship products include the Covishield vaccine, a key player in the global fight against COVID-19. The institute’s contributions to public health have been recognized worldwide, significantly reducing mortality rates and improving life expectancy in underserved regions.
The Serum Institute of India has a significant presence in Africa, supplying vaccines to numerous countries across the continent. Its strategic distribution networks ensure that life-saving vaccines reach remote and underserved areas, contributing to improved healthcare outcomes in regions such as Sub-Saharan Africa and North Africa.
The institute’s key initiatives include partnerships with global health organizations like Gavi, the Vaccine Alliance, and the World Health Organization. These collaborations focus on increasing vaccine accessibility and affordability. The institute also invests in research and development to innovate and expand its vaccine offerings, addressing emerging health challenges.
The Serum Institute has achieved significant milestones, including the production of over 1.5 billion vaccine doses annually and the development of the Covishield vaccine, which has been pivotal in the global COVID-19 vaccination effort. Its vaccines have contributed to the reduction of disease prevalence and mortality rates, particularly in low-income countries.
